Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 4

COVID-19 et oseltamivir (TamifluMC)

Institut National d’Excellence en Santé et en Services Sociaux.
CONTEXTE: Le présent document ainsi que les constats et prises de position qu’il énonce ont été rédigés en réponse à une interpellation du ministère de la Santé et des Services sociaux dans le contexte de l’urgence sanitaire liée à la maladie à coronavirus (COVID-19) au Québec. Cette po...
Coronavirus Infections/drug therapy, Betacoronavirus/drug effects, Oseltamivir/therapeutic use, Technology Assessment, Biomedical, Health Evaluation
Fulltext

Revisão rápida sobre alternativas terapêuticas para Coronavírus Humano: atualização

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
Objetivo: identificar evidências científicas acerca do tratamento para indivíduos infectados por COVID-19. Metodologia: foi realizada atualização da revisão rápida conduzida pela equipe do Núcleo de Evidências em janeiro de 2020. Foram consultadas as bases de dados Medline (via Pubmed), EMBASE, ...
Coronavirus Infections/drug therapy, Antibiotic Prophylaxis/instrumentation, Oseltamivir/therapeutic use, Methylprednisolone/therapeutic use, Oxygen Inhalation Therapy/instrumentation, Pulmonary Ventilation, Brazil, Coronavirus Infections/therapy, Technology Assessment, Biomedical
Fulltext

Uso de oseltamivir para el tratamiento de pacientes con COVID-19

Peru. EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación.
INTRODUCCIÓN: Oseltamivir (Tamiflu ®) es un producto farmacéutico con indicación para el tratamiento y prevención de la gripe por influenza en adultos y en niños1 . A la fecha, ninguna organización internacional, incluyendo la CDC de EEUU2 o la OMS3 ha establecido recomendaciones específicas para...
Oseltamivir/therapeutic use, Coronavirus Infections/drug therapy, Technology Assessment, Biomedical, Brazil
Fulltext

Informe diário de evidências: COVID-19 busca realizada em 22 de abril de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência,Tecnologia e Insumos Estratégicos em Saúde.
O objetivo da revisão sistemática foi investigar a eficácia e a segurança de tratamentos com antivirais para COVID-19, SARS e MERS. Ao todo, 22 estudos foram incluídos: 1 ensaio clínico, 16 séries de casos e 5 relatos de caso. Os antivirais mais utilizados foram lopinavir / ritonavir, oseltamivir,...
Betacoronavirus/drug effects, Pneumonia, Viral/drug therapy, Coronavirus Infections/drug therapy, Anti-Retroviral Agents/administration & dosage, Oseltamivir/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Ribavirin/therapeutic use, Antiparasitic Agents/administration & dosage, Antifungal Agents/administration & dosage, Therapies, Investigational/instrumentation, Disease Progression, Technology Assessment, Biomedical
Fulltext